NCT00519116View on ClinicalTrials.gov

Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 31, 2000

Study Completion Date

August 31, 2001

Conditions
Kidney Transplantation
Interventions
DRUG

Rapamune® (Sirolimus)

DRUG

Tacrolimus

DRUG

Perioperative Corticosteroids

The corticosteroids use was left up to the investigators decision.

All Listed Sponsors
lead

Wyeth is now a wholly owned subsidiary of Pfizer

INDUSTRY

NCT00519116 - Study Comparing Standard Dose and Reduced Dose Tacrolimus With Sirolimus in Renal Transplant Patients | Biotech Hunter | Biotech Hunter